Novocaine is in theaters on March 14, 2025. Edgar Wright made a name for himself with action comedies like Shaun of the Dead and Scott Pilgrim vs. the World – movies where normal, flawed dudes ...

Furosemide injection was previously approved to treat ... no additional clinical trials would be needed to approve the label expansion. 2 “Expanding the [furosemide] indication to include ...

A weight loss medication mania continues to sweep across the country. Cooper Kupp Shared His Blunt Conversation With Sean McVay About Rams Trade 10 Box Office Flops That Are Actually Brilliant ...

China plans to inject billions of dollars into its banking system in the coming month as it ramps up efforts to reinvigorate its struggling economy. The government aims to dole out at least 400 ...

Indivior PLC, a global leader in addiction treatment, announced that the US Food and Drug Administration (FDA) has approved label changes for Sublocade including a rapid initiation protocol and ...

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

For most of Bladee's career, the Swedish rapper released almost all of his full-length material with the Stockholm-based label YEAR0001. That came to an end in 2024 with the release of his solo ...

Russell owns the label XL Recordings, whose roster has included Radiohead and Adele. He also makes his own studio albums, with widely assorted collaborators, under the rubric Everything Is Recorded.

has approved label changes for SUBLOCADE ® including a rapid initiation protocol and alternative injection sites, marking a significant advancement in the treatment of moderate to severe opioid ...

Rapid initiation Protocol: Healthcare providers can now initiate treatment with SUBLOCADE after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm tolerability.

Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE ® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) These FDA ...